Bioterrorism
Biodefense support agreement inked with GE Healthcare
Published in Medical Letter on the CDC and FDA, January 29th, 2006
GE Healthcare's Fast Trak BioDefense group has a staff of technical and regulatory experts who will collaborate with CytoGenix in seeking, obtaining, and executing biodefense-related federal contracts.
Frank Vazquez, CytoGenix, Inc., executive vice president and COO, commented, "Our association with GE Healthcare, a $14 billion entity of GE, as partners in competing for federal research projects sends a very positive message to grant reviewers and granting agencies at the U.S. Department of Homeland...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Diet & Nutrition
Urinary phyto-estrogen concentrations in U.S. population are presented - Respiratory Diseases
U.S. CDC issues new guidelines for detection of tuberculosis - Sexually Transmitted Disease
Trends in sexual behavior in general and minority populations are diverging - Vaccine Safety
Poliovirus vaccine shedding is minimal among people infected with HIV - Abortion
Studies evaluate misoprostol use to terminate pregnancies in Latin America - Addiction Medicine
Agency issues approvable letter for Vivitrol for treatment of alcohol dependence - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
